ARROWHEAD PHARMACEUTICALS IN
ARWR·04280A100·US·Common Stock·Healthcare - Biotechnology-Activist
ARWR (ARROWHEAD PHARMACEUTICALS IN) is held by 222 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($1.2B), Avoro Capital Advisors LLC ($925.6M), FMR LLC ($655.3M). Net institutional sentiment: Mixed.
222
Holders
(18 Elite)
$8.7B
Total Value
48% (218)
Consensus
104 buying - 114 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 9, 2026 · Insiders Aug 20, 2026 · Activists Aug 14, 2026 · Congress none
InsiderPSPERRY MICHAEL SSell $1.0MAug 18, 2026
InsiderOYOLUKOTUN ADEOYE YSell $174KAug 18, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 231
1 / 12
Continue exploring
Other Healthcare stocks held by institutions
415 holders · $877.5B
415 holders · $299.1B
400 holders · $151.4B
397 holders · $414.1B
394 holders · $97.5B
393 holders · $111.5B
390 holders · $230.1B
385 holders · $302.9B
385 holders · $51.8B
382 holders · $113.8B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer